Liver
Liver cancer is a serious disease that develops in the liver cells, with hepatocellular carcinoma (HCC) being the most common type. Risk factors include chronic hepatitis infections, excessive alcohol consumption, and fatty liver disease.
Breakthrough nanoparticle delivery method targets brain inflammation for multiple conditions
Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and cancer cachexia.
A new drug delivery system may help patients with a rare eye cancer
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver.
Research Shows Vitamin D Enhances Cancer Treatment Outcomes
While any single vitamin can’t cure all types of ailments and diseases, there’s one nutrient that has been shown to deliver incredible support for immune function time and time again
Liver transplants offer new hope for colorectal cancer patients with liver metastasis
Liver transplants are becoming a new treatment option for certain colorectal cancer patients whose cancer has spread to their liver and are ineligible for other surgical options.
Type 2 diabetes increases risk of liver and pancreatic cancers, study shows
Chance of developing some of the most lethal tumours up to five times higher in women recently diagnosed with condition
Ultrasound technology offers non-invasive treatment for liver cancer
AUSTIN (KXAN) — A new technology is giving doctors a non-invasive method for treating liver cancer, without requiring incisions or surgery.
Nanoparticle immune therapy shows potential to halt pancreatic cancer spread
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of pancreatic cancer patients experience metastasis to the liver, which worsens the prognosis for an already life-threatening disease.
The timing breakthrough in liver cancer treatment
In a significant step forward for liver cancer treatment, researchers have found that a gap of at least 50 days between stopping immunotherapy and undergoing a liver transplant dramatically lowers the risk of graft rejection. This discovery offers new hope to patients battling hepatocellular carcinoma (HCC), the most common form of liver cancer globally.
Self-protecting nanoparticles can enhance colorectal cancer drug delivery
Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral administration of anticancer drugs that pass through the gastrointestinal (GI) tract into the colorectum is a common strategy to deliver drugs in CRC treatment.
Common chemical in everyday products may raise your liver cancer risk
Scientists from the University of Southern California have found that exposure to a widely used synthetic chemical is linked to a higher risk of developing liver cancer. The chemical, called perfluorooctane sulfate (PFOS), belongs to a group of man-made substances known as per- and polyfluoroalkyl substances (PFAS).
Geneva researchers discover potential for targeted cancer drug delivery
Researchers in Geneva have determined how some harmful bacteria introduce dangerous enzymes into host cells. They now want to use this discovery to deliver drugs directly to cancer cells.
Rice scientists create nasal drug to sniff out pancreatic cancer
Scientists have created a nasal drug delivery system using amifostine to protect healthy tissues during pancreatic cancer radiation therapy.
